{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:17:18Z","timestamp":1773472638438,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.canlet.2017.08.041","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T17:51:35Z","timestamp":1504720295000},"page":"42-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes"],"prefix":"10.1016","volume":"409","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-6192","authenticated-orcid":false,"given":"Rosa","family":"Collado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Puiggros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"L\u00f3pez-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Jos\u00e9","family":"Calasanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Jos\u00e9","family":"Larr\u00e1yoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ivars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaida","family":"Garc\u00eda-Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eug\u00e8nia","family":"Abella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Teresa","family":"Orero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Talavera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carla","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas Ma","family":"Hern\u00e1ndez-Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Hern\u00e1ndez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Lu\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Valiente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Portal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Gardella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Camino","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Teresa","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Teresa","family":"Ardanaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Campeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Julio","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Espinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Carbonell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2017.08.041_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2011.02.002","article-title":"Importance of genetics in chronic lymphocytic leukemia","volume":"25","author":"Zenz","year":"2011","journal-title":"Blood Rev."},{"key":"10.1016\/j.canlet.2017.08.041_bib2","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2017.08.041_bib3","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1002\/cncr.29566","article-title":"Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens","volume":"121","author":"Thompson","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2017.08.041_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.23618","article-title":"Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data","volume":"89","author":"Baliakas","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.canlet.2017.08.041_bib5","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.17350","article-title":"Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53\/ATM FISH deletions","author":"Puiggros","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.08.041_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/leu.2014.196","article-title":"Recurrent mutations refine prognosis in chronic lymphocytic leukemia","volume":"29","author":"Baliakas","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2017.08.041_bib7","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood-2015-07-659144","article-title":"Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia","volume":"127","author":"Nadeu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2141.2011.09000.x","article-title":"Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results","volume":"157","author":"Delgado","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2017.08.041_bib9","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1200\/JCO.2008.21.1128","article-title":"Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group","volume":"27","author":"Stilgenbauer","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.08.041_bib10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1078-0432.CCR-08-1630","article-title":"The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness","volume":"15","author":"Rossi","year":"2009","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.canlet.2017.08.041_bib11","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2009.27.8762","article-title":"TP53 mutation and survival in chronic lymphocytic leukemia","volume":"28","author":"Zenz","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.08.041_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000443903","article-title":"State-of-the-Art treatment and novel agents in chronic lymphocytic leukemia","volume":"39","author":"Cramer","year":"2016","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.canlet.2017.08.041_bib13","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1182\/blood-2009-07-234708","article-title":"Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage","volume":"114","author":"Malcikova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/leu.2008.260","article-title":"A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease","volume":"23","author":"Best","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2017.08.041_bib15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2009-03-210591","article-title":"De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience","volume":"114","author":"Tam","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib16","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.3324\/haematol.2014.108365","article-title":"Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption","volume":"99","author":"Delgado","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2017.08.041_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/1078-0432.CCR-16-0594","article-title":"Survival of Del17p CLL depends on genomic complexity and somatic mutation","volume":"23","author":"Yu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.08.041_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/gcc.20794","article-title":"Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters","volume":"49","author":"Haferlach","year":"2010","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.canlet.2017.08.041_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cancergencyto.2006.01.005","article-title":"Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia","volume":"167","author":"Fink","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.canlet.2017.08.041_bib20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.2011.08978.x","article-title":"A new genetic abnormality leading to TP53 gene deletion in chronic lymphocytic leukaemia","volume":"156","author":"Lopez","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2017.08.041_bib21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2005-05-2093","article-title":"Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia","volume":"107","author":"Mayr","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/gcc.2870100402","article-title":"Isochromosomes in neoplasia","volume":"10","author":"Mertens","year":"1994","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.canlet.2017.08.041_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1182\/blood.V94.1.225.413k24_225_232","article-title":"Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations","volume":"94","author":"Fioretos","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib24","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1002\/cncr.26537","article-title":"Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic\/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53","volume":"118","author":"Kanagal-Shamanna","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2017.08.041_bib25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2141.1999.01537.x","article-title":"Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder\/myelodysplastic syndrome with an aggressive clinical course","volume":"106","author":"McClure","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2017.08.041_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1309\/WB56ET6AGM44TM5T","article-title":"Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis","volume":"128","author":"Amato","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2017.08.041_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2141.1993.tb03337.x","article-title":"Cytogenetic studies in splenic lymphoma with villous lymphocytes","volume":"85","author":"Oscier","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2017.08.041_bib28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/blood-2013-07-515155","article-title":"Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?","volume":"123","author":"Xochelli","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib29","article-title":"Isochromosome 17q in chronic lymphocytic leukemia","volume":"2015","author":"Alhourani","year":"2015","journal-title":"Leuk. Res. Treat."},{"key":"10.1016\/j.canlet.2017.08.041_bib30","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on chronic lymphocytic leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib31","series-title":"ISCN (2016): an International System for Human Cytogenetic Nomenclature","author":"McGowan-Jordan","year":"2016"},{"key":"10.1016\/j.canlet.2017.08.041_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.leu.2404457","article-title":"ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia","volume":"21","author":"Ghia","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2017.08.041_bib33","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/leu.2012.25","article-title":"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia","volume":"26","author":"Pospisilova","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2017.08.041_bib34","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.canlet.2017.08.041_bib35","doi-asserted-by":"crossref","first-page":"28008","DOI":"10.18632\/oncotarget.15883","article-title":"An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness","volume":"8","author":"Rigolin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.08.041_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/380648","article-title":"The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats","volume":"74","author":"Barbouti","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.canlet.2017.08.041_bib37","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1101\/gr.080697.108","article-title":"Copy number variation at the breakpoint region of isochromosome 17q","volume":"18","author":"Carvalho","year":"2008","journal-title":"Genome Res."},{"key":"10.1016\/j.canlet.2017.08.041_bib38","doi-asserted-by":"crossref","first-page":"14251","DOI":"10.18632\/oncotarget.7350","article-title":"Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS","volume":"7","author":"Kanagal-Shamanna","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.08.041_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bjh.13355","article-title":"Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations","volume":"171","author":"Adema","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2017.08.041_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2353\/jmoldx.2010.090192","article-title":"Array comparative genomic hybridization detects chromosomal abnormalities in hematological cancers that are not detected by conventional cytogenetics","volume":"12","author":"Shao","year":"2010","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.canlet.2017.08.041_bib41","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/10428194.2012.731598","article-title":"Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?","volume":"54","author":"Puiggros","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.canlet.2017.08.041_bib42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1365-2141.2011.08789.x","article-title":"Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia","volume":"154","author":"Rinaldi","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2017.08.041_bib43","doi-asserted-by":"crossref","first-page":"80916","DOI":"10.18632\/oncotarget.13106","article-title":"Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations","volume":"7","author":"Blanco","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.08.041_bib44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2141.2008.07373.x","article-title":"Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion","volume":"143","author":"Forconi","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2017.08.041_bib45","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib47","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/blood-2011-11-366062","article-title":"Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies","volume":"119","author":"Xu-Monette","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib48","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2017.08.041_bib49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4614-8051-8_4","article-title":"Recurrent gene mutations in CLL","volume":"792","author":"Martinez-Trillos","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.canlet.2017.08.041_bib50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2141.2000.02335.x","article-title":"p53 intronic point mutation, aberrant splicing and telomeric associations in a case of B-chronic lymphocytic leukaemia","volume":"111","author":"Bromidge","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2017.08.041_bib51","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1038\/sj.onc.1203758","article-title":"Novel p53 splice site mutations in three families with Li-Fraumeni syndrome","volume":"19","author":"Verselis","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.08.041_bib52","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1200\/JCO.2011.34.7872","article-title":"Missense mutations located in structural p53 DNA-binding motifs are associated with extremely poor survival in chronic lymphocytic leukemia","volume":"29","author":"Trbusek","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.08.041_bib53","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2017-03-772285","article-title":"In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI","volume":"129","author":"Rigolin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.08.041_bib54","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.leukres.2013.04.010","article-title":"Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome","volume":"37","author":"Sanchez-Castro","year":"2013","journal-title":"Leuk. Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517305360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517305360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T19:10:53Z","timestamp":1719429053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383517305360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":54,"alternative-id":["S0304383517305360"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2017.08.041","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2017.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}